Bill Analyses and Ratings
Bill Information: H0899 – Medical Advanced Healing Act (MAHA) Pilot Program
Bill Summary
House Bill 899 creates the Medical Advanced Healing Act (MAHA), establishing a new pilot program under the Idaho Department of Health and Welfare that authorizes supervised clinical use of psilocybin, MDMA, and ibogaine for eligible Idaho residents aged 21 and older. Access is initially limited to veterans, first responders, and individuals with addiction or serious behavioral health conditions including PTSD, major depressive disorder, and substance use disorder. The program requires rigorous safety protocols including medical and psychiatric screening, informed consent, supervised administration sessions, secure storage, and inventory controls to prevent diversion.
The bill creates a dedicated MAHA Fund financed through licensing fees, per-session program fees, and voluntary grants or donations — explicitly prohibiting reliance on general fund appropriations unless future legislation authorizes it. The Department of Health and Welfare is granted broad rulemaking authority to establish certification and training requirements, licensing standards, clinical protocols, and enforcement mechanisms. All rules are subject to legislative approval, and the legislature retains full authority to modify, expand, or discontinue the program at any time.
Beginning one year after services commence, the department must report annually to the governor and relevant legislative committees on participant numbers, session types, safety outcomes, clinical results, and program finances. The bill aligns with the 2024 National Defense Authorization Act, which permits states to partner with the federal government to study these substances for treating serious behavioral health conditions, and references $10 million in federal funding already directed toward such research.
Overall Assessment
This bill’s most significant impact is on Idaho veterans and first responders suffering from PTSD, depression, and addiction who have not found relief through conventional treatments — giving them supervised clinical access to psilocybin, MDMA, and ibogaine for the first time under state law. The program imposes new regulatory infrastructure on service providers, including licensing, certification, inspections, and per-session fees, which creates compliance costs for any entity operating within the program. While the revenue-neutral funding model and strong legislative oversight provisions reflect fiscal discipline, the expansion of state health and welfare rulemaking authority over a new class of controlled substances introduces meaningful regulatory complexity.
Rating Breakdown
ARTICLE I. Responsibility in Government (1)
Section 39-6903(4) explicitly requires the pilot program to be administered in a revenue-neutral manner, funded through program fees and voluntary grants rather than ongoing general fund appropriations. Section 39-6909 subjects all department rules to legislative approval, and Section 39-6903(6) preserves the legislature's full authority to modify, expand, limit, or discontinue the program — ensuring elected officials retain direct accountability over the program's direction and costs.
ARTICLE II. Citizen Involvement in Government (0)
The bill creates a regulated healthcare pilot program and does not address citizen participation in elections, civic education, or political processes. Section 39-6906(2) requires the department to consult with stakeholders during rulemaking, which is a standard administrative procedure rather than a meaningful expansion or restriction of citizen involvement in government.
ARTICLE III. Education (0)
The bill is confined to healthcare regulation and contains no provisions touching education policy, school funding, curriculum, parental rights in schooling, or teacher workforce issues. Its scope is entirely limited to the administration of a medical pilot program.
ARTICLE IV. Agriculture (0)
No provisions in this bill relate to agricultural markets, farm operations, water law as it pertains to agriculture, or rural economic development tied to farming. The bill's subject matter — supervised clinical use of neuroplastogens — has no intersection with Idaho's agricultural sector.
ARTICLE V. Water (0)
The bill contains no provisions related to water rights, water appropriation, irrigation infrastructure, or dam and reservoir management. Its regulatory scope is entirely within the domain of behavioral health treatment.
ARTICLE VI. Natural Resources and Environment (0)
Nothing in this bill addresses natural resource extraction, environmental stewardship, federal land policy, wilderness management, or forest use. The bill's provisions are limited to a clinical healthcare program administered by the Department of Health and Welfare.
ARTICLE VII. Energy (0)
The bill has no connection to energy production, energy independence, utility rates, or resource development. Its entire scope concerns the supervised therapeutic use of specific substances for behavioral health conditions.
ARTICLE VIII. Idaho National Laboratories (0)
The bill makes no reference to the Idaho National Laboratories, nuclear energy research, or technology transfer initiatives. It operates entirely within the behavioral health and medical regulation domain.
ARTICLE IX. Private Property Rights (0)
The bill does not create any new takings authority, restrict property development, or alter due process protections related to property. Its licensing and regulatory provisions apply to program operators and participants in a clinical setting, not to property ownership or use.
ARTICLE X. State and Federal Lands (0)
The bill contains no provisions concerning state or federal land ownership, management transfers, or public land access. Its subject matter is confined to a state-administered healthcare pilot program.
ARTICLE XI. Wildlife Management (0)
No provisions in this bill relate to fish and game management, hunting and fishing rights, predator control, or wildlife habitat. The bill's regulatory framework is entirely focused on human behavioral health treatment.
ARTICLE XII. Economy (-1)
Section 39-6906 requires entities operating within the program to obtain licenses, undergo inspections, meet security requirements, and satisfy certification and training standards — all of which impose compliance costs on service providers. Section 39-6907 authorizes per-session program fees and licensing fees, adding direct financial burdens on program operators. While the program creates a new service market, the net regulatory load on businesses entering this space is a meaningful cost increase without offsetting deregulatory provisions.
ARTICLE XIII. Health and Welfare (-1)
The bill significantly expands the Idaho Department of Health and Welfare's rulemaking authority, granting it power to define qualifying conditions, set clinical protocols, establish licensing standards, and regulate sourcing, testing, and disposal of controlled substances under Section 39-6906. While the program aims to help underserved populations, it creates a large new administrative apparatus with broad discretionary authority over who qualifies for treatment and under what conditions — concentrating substantial power in a state agency over sensitive medical decisions. The department's ability to expand qualifying conditions by rule under Section 39-6904(5) further extends this authority beyond what the legislature explicitly defined.
ARTICLE XIV. American Family (0)
The bill targets adult individuals aged 21 and older with specific clinical diagnoses and does not address family structure, parental rights, marriage, child welfare, or reproductive policy. Its provisions are narrowly focused on individual participant eligibility and clinical safety standards.
ARTICLE XV. Older Americans (0)
While the program is open to all eligible adults 21 and older, the bill contains no provisions specifically designed to address the needs of older Idahoans, senior services, retirement security, or age-related workforce policies. Older adults with qualifying conditions may participate, but they receive no targeted benefit or protection under the bill's terms.
ARTICLE XVI. Law and Order with Justice (0)
Section 39-6905 creates a legal carve-out permitting possession and consumption of otherwise controlled substances — psilocybin, MDMA, and ibogaine — within supervised program sessions, which represents a notable change to Idaho's controlled substance landscape. However, the bill does not alter criminal sentencing, law enforcement procedures, or judicial processes, and unsupervised use remains prohibited under Section 39-6905(3), preserving existing criminal law outside the program's boundaries.
ARTICLE XVII. National Defense - Securing the Border (1)
Section 39-6903(2) explicitly limits initial program access to veterans and first responders, and Section 39-6903(3)(b) states a direct program goal of improving access to emerging therapeutic options for Idaho veterans. The bill's legislative findings in Section 39-6902 acknowledge that veterans and first responders suffering from job-related trauma are a primary population inadequately served by existing treatments, making their care a central purpose of the legislation.
ARTICLE XVIII. Election of Judges and Idaho Supreme Court Justices (0)
The bill contains no provisions related to judicial selection, retention elections, judicial philosophy, or court structure. Its scope is entirely confined to a behavioral health pilot program administered by the executive branch.
ARTICLE XIX. Religious Liberty (0)
The bill does not restrict or expand religious exercise, impose requirements on religious organizations, or address conscience protections. Section 39-6905(2)(e) requires ethical standards to prevent exploitation and abuse, but this is a clinical conduct standard with no religious liberty implications.